Journal Information

Statistics

Follow this link to access the full text of the article

Artículo especial
Abemaciclib en adyuvancia para el tratamiento del cáncer de mama precoz de alto riesgo
Abemaciclib as adjuvant treatment for high-risk early breast cancer
Ana Ganfornina Andradesa,
Corresponding author
anaganand@gmail.com

Autor para correspondencia.
, Silvia Fénix Caballerob, Alba Salguero Olidc, Emilio Jesús Alegre Del-Reyb
a Departamento de Farmacia, Hospital General Tomelloso, Tomelloso, Ciudad Real, España
b Departamento de Farmacia, Hospital Universitario Puerto Real, Puerto Real, Cádiz, España
c Departamento de Farmacia, Hospital La Merced, Osuna, Sevilla, España
Read
6141
Times
was read the article
1138
Total PDF
5003
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2025 June 32 6 38
2025 May 464 65 529
2025 April 324 59 383
2025 March 375 60 435
2025 February 333 62 395
2025 January 248 68 316
2024 December 237 49 286
2024 November 294 74 368
2024 October 283 67 350
2024 September 295 55 350
2024 August 253 66 319
2024 July 206 45 251
2024 June 213 58 271
2024 May 286 77 363
2024 April 369 130 499
2024 March 354 70 424
2024 February 208 48 256
2024 January 182 50 232
2023 December 47 29 76
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.